118 related articles for article (PubMed ID: 7881339)
21. Permanent cessation of menses and postmenopausal hormone use in dialysis-dependent women: the HELP study.
Kramer HM; Curhan GC; Singh A;
Am J Kidney Dis; 2003 Mar; 41(3):643-50. PubMed ID: 12612988
[TBL] [Abstract][Full Text] [Related]
22. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for stress, urge or mixed urinary incontinence in Italy.
Parazzini F; Chiaffarino F; Lavezzari M; Giambanco V;
BJOG; 2003 Oct; 110(10):927-33. PubMed ID: 14550363
[TBL] [Abstract][Full Text] [Related]
24. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
Brinton LA; Hoover RN
Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
[TBL] [Abstract][Full Text] [Related]
25. The association of socio-economic position across the life course and age at menopause: the British Women's Heart and Health Study.
Lawlor DA; Ebrahim S; Smith GD
BJOG; 2003 Dec; 110(12):1078-87. PubMed ID: 14664879
[TBL] [Abstract][Full Text] [Related]
26. Changes in Lp(a) lipoprotein and lipid levels after cessation of female sex hormone production and estrogen replacement therapy.
Kim CJ; Ryu WS; Kwak JW; Park CT; Ryoo UH
Arch Intern Med; 1996 Mar; 156(5):500-4. PubMed ID: 8604955
[TBL] [Abstract][Full Text] [Related]
27. Tanning bed exposure increases the risk of malignant melanoma.
Ting W; Schultz K; Cac NN; Peterson M; Walling HW
Int J Dermatol; 2007 Dec; 46(12):1253-7. PubMed ID: 18173518
[TBL] [Abstract][Full Text] [Related]
28. Unopposed estrogen therapy and the risk of invasive breast cancer.
Chen WY; Manson JE; Hankinson SE; Rosner B; Holmes MD; Willett WC; Colditz GA
Arch Intern Med; 2006 May; 166(9):1027-32. PubMed ID: 16682578
[TBL] [Abstract][Full Text] [Related]
29. Noncontraceptive estrogen use and the occurrence of ovarian cancer.
Weiss NS; Lyon JL; Krishnamurthy S; Dietert SE; Liff JM; Daling JR
J Natl Cancer Inst; 1982 Jan; 68(1):95-8. PubMed ID: 6948131
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use.
Holly EA; Cress RD; Ahn DK
Am J Epidemiol; 1995 May; 141(10):943-50. PubMed ID: 7741124
[TBL] [Abstract][Full Text] [Related]
31. [Statistical study of the risk of cardiovascular disease in hysterectomized patients].
Pastore G; Benedetto C; Ardizzoja M; Cavallero G; Massobrio M
Minerva Med; 1985 Apr; 76(17-18):827-34. PubMed ID: 3889720
[TBL] [Abstract][Full Text] [Related]
32. Incidence of ovulation from the menarche to the menopause: observations of 622 New Zealand women.
Metcalf MG
N Z Med J; 1983 Aug; 96(738):645-8. PubMed ID: 6576257
[TBL] [Abstract][Full Text] [Related]
33. Cognitive functioning in elderly women who underwent unilateral oophorectomy before menopause.
Zhou G; Liu J; Sun F; Duan L; Yan B; Peng Q
Int J Neurosci; 2011 Apr; 121(4):196-200. PubMed ID: 21198412
[TBL] [Abstract][Full Text] [Related]
34. [Ovarian function after hysterectomy].
Dördelmann P; Wölker H
Munch Med Wochenschr; 1968 Sep; 110(37):2061-7. PubMed ID: 5756395
[No Abstract] [Full Text] [Related]
35. Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study.
Benedetti MD; Maraganore DM; Bower JH; McDonnell SK; Peterson BJ; Ahlskog JE; Schaid DJ; Rocca WA
Mov Disord; 2001 Sep; 16(5):830-7. PubMed ID: 11746612
[TBL] [Abstract][Full Text] [Related]
36. Menopausal Hormone Therapy and Risk of Melanoma: A Nationwide Register-Based Study in Finland.
Botteri E; Støer NC; Weiderpass E; Pukkala E; Ylikorkala O; Lyytinen H
Cancer Epidemiol Biomarkers Prev; 2019 Nov; 28(11):1857-1860. PubMed ID: 31455672
[TBL] [Abstract][Full Text] [Related]
37. Hormonal factors and melanoma in women.
Green A; Bain C
Med J Aust; 1985 Apr; 142(8):446-8. PubMed ID: 3982348
[TBL] [Abstract][Full Text] [Related]
38. Use of postmenopausal hormones and risk of myocardial infarction.
Bain C; Willett W; Hennekens CH; Rosner B; Belanger C; Speizer FE
Circulation; 1981 Jul; 64(1):42-6. PubMed ID: 7237723
[TBL] [Abstract][Full Text] [Related]
39. Oestrogens for women: the risk/benefit ratio.
McKenna TJ
Ir Med J; 1987 Aug; 80(8):219-21. PubMed ID: 3308765
[No Abstract] [Full Text] [Related]
40. [Hormonal activity in women after hysterectomy and castration before and after balneological therapy].
Marzinek K; Witkowska E; Pietrusiewicz W; Wójcik M; Sternadel Z
Pol Tyg Lek; 1983 Oct; 38(41):1275-6. PubMed ID: 6672803
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
